Pilots and Feasibility Program

G.摘要（试点和可行性方案） 试点和可行性计划为新项目提供了难以确定的启动资金， 从NORC的协同效应中获益。该计划的主要优势是我们的高年级临界质量 科学家在彭宁顿谁激励年轻的研究人员（高级博士后研究员，导师和 助理教授）通过加强沟通和丰富的NORC活动。这 协同作用产生新的研究思路。 试点和可行性方案的目标是： 1)鼓励围绕我们预先确定的主题“营养， 肥胖和代谢健康贯穿一生。” 2)为初级学院（和一些有前途的博士后）实施新的研究 研究员） 3)吸引更多的资深教师围绕我们的主题“营养，肥胖”从事新的研究路线 和终生代谢健康。” 4)收集足够的初步数据，作为NIH R 01、R 03、R21和P01申请的基础。 5)从慈善机构和/或私人公司寻求额外的无限制资金。 6)提供一个基于网络的平台，以促进和简化试点和可行性提案的提交， 审查和跟踪已发放的赠款。 选定的研究建议将获得资助，以支持项目的直接费用（15，000 - 35，000美元） 再加上NORC核心的使用虽然该计划对每个项目的支持水平是 相对较少的这种类型的启动资金往往是最难确定的研究 设置.

G. Abstract (Pilot and Feasibility Program) The Pilot and Feasibility Program provides the hard-to-identify start-up funds for new projects that emanate from the synergies fostered in the NORC. A major strength of this program is our critical mass of senior scientists at Pennington who energize young investigators (senior Postdoctoral Fellows, Instructors and Assistant Professors) through enhanced communications and enrichment activities of the NORC. This synergism produces new research ideas. The aims of the Pilot and Feasibility Program are to: 1) Encourage n e w innovative r e s e a r c h p r o j e c t s around our pre-identified theme of “ Nutrition, Obesity and Metabolic Health Throughout the Lifespan.” 2) Enable the implementation of new research for Junior Faculty (and some promising postdoctoral fellows) in nutrition research 3) Entice more senior Faculty to engage in a new line of research around our theme of “ Nutrition, Obesity and Metabolic Health Throughout the Lifespan.” 4) Collect adequate preliminary data to serve as a basis for NIH R01, R03, R21 and P01 applications. 5) Seek additional unrestricted funding from philanthropy and/or private companies. 6) Provide a web-based platform to facilitate and streamline Pilot and Feasibility proposal submission, review, and tracking of awarded grants. The selected research proposals receive funds to support direct costs ($15,000 - $35,000) of the project plus use of the NORC Cores. Although the level of support from this program for each individual project is relatively modest this type of start-up funding is frequently the most difficult to identify in the research setting.